Structured as a combination of secondary investment and company-sponsored buyback, it provides liquidity to Axtria’s current and former employees, it said. Founded in 2010, Axtria enables AI-led solutions that help life sciences organizations globally, across the commercial and clinical spectrum.
from Tech-Economic Times https://ift.tt/9HuPc0N
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
The Devas shareholders are enforcing an International Chamber of Commerce arbitral award of $1.2 billion to Devas, owed by ISRO commercial a...
No comments:
Post a Comment